23andme Holding Co (ME) Return on Assets ROA from the first quarter of 2026 to first quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2025 to Jun 30 2024 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
23andme Holding Co  (ME)


23andme Holding Co's ROA from the first quarter of 2026 to the first quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is 23andme Holding Co's ROA in the first quarter of 2026?
23andme Holding Co recorded a cumulative net loss of $-235 million during 12 months ending in the first quarter of 2026, resulting in a negative return on assets (ROA) of -118.38%.

However, within the Healthcare sector 793 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2025 quarter, so far to 4469, from total ROA ranking in the fourth quarter of 2025 at 4522.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2025)
I. Quarter		 (Mar 31 2025)
IV. Quarter		 (Dec 31 2024)
III. Quarter		 (Sep 30 2024)
II. Quarter		 (Jun 30 2024)
I. Quarter
Y / Y Total Assets Change -55.11 % -60.14 % -58.23 % -64.24 % -61.29 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -235 -281 -390 -615 -631
Return On Assets (TTM) -118.38 % -115.99 % -129.81 % -161.32 % -125.97 %
ME's Total Ranking # 4469 # 4522 # 5288 # 4754 # 4719
Total Assets (TTM) in million 141 155 232 267 315
Seq. Total Assets Change -9 % -32.94 % -13.22 % -15.23 % -19.18 %
Seq. Net Income Change - - - - -

ME's 5 Years Annual ROA >> Back to ME Management Effectiveness >> Compare ME ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 369
Sector # 794
Overall # 4410

Return On Assets Statistics
High Average Low
-13.91 %
-64.23 %
-145.61 %
(Dec 31 2021)   (Sep 30 2024)



  News about 23andme Holding Co Return on Assets ROA

23andMe Regains Compliance With Nasdaq Listing Requirements

23andMe’s Strategic Maneuvers: Regaining Nasdaq Compliance Amidst Corporate RestructuringIn a compelling demonstration of resilience and strategic foresight, 23andMe Holding Co. (Nasdaq: ME) has successfully maneuvered through challenges that jeopardized its listing on the Nasdaq Capital Market. On October 30, 2024, the company announced that it has regained compliance with Nasdaq’s listing requirements, resolves that could have hindered its trading capability and market presence.23andMe, a leader in human genetics and preventive health, had faced scrutiny over its stock performance. The closure of its Class A common stock above the required minimum bid price, stipulated under Nasdaq Listing Rule 5550(a)(2), became a focal point of concern. The company’s proactive measures have led to a turnaround, enabling it to maintain its stock on this prominent exchange and continue trading under the symbol ME.



Financial Statements
23andme Holding Co's Assets $ 141 million ME's Balance sheet
23andme Holding Co's Income $ -24 million Quarterly ME's Income Statement
ME's Income by Division See ME's Income by Division



Annual Return On Assets (Mar 31 2025)
FY 2025		 (Mar 31 2024)
FY 2024		 (Mar 31 2023)
FY 2023		 (Mar 31 2022)
FY 2022
FY
Y / Y Total Assets Change -54.58 % -61.27 % -19.32 % - -
Total Assets in million 155 342 883 1,094 0
Y / Y Net Income Change - - - - -
Net Income in million -281 -667 -312 -217 0
Annual Return On Assets -180.87 % -194.99 % -35.3 % -19.88 % -

ME's 5 Years Annual ROA >> Back to ME Management Effectiveness >> Compare ME ROA to its Competitors



More Return On Assets Ratios
ME's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ME's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for ME's Competitors
Subscribers only: Roa for 23andme Holding Co's Suppliers
Subscribers only: Return On Assets for ME's Customers

You may also want to know
ME's Roi ME's Inventory Turnover Ratio ME's Growth Rates ME's Dividend Comparisons
ME's Profitability Ratios ME's Asset Turnover Ratio ME's Dividend Growth
ME's Roe ME's Valuation Ratios ME's Financial Strength Ratios ME's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2025, within Healthcare Sector ROA

Date modified: 2026-09-08T18:53:26+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.